PNO: Catheter, Percutaneous, Cutting/Scoring

Product code PNO, “Catheter, Percutaneous, Cutting/Scoring” in FDA's classification database, is a Class II device type under 21 CFR 870.1250 (percutaneous catheter), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 46 clearances under PNO, 29 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
PNO
Regulation
21 CFR 870.1250
Class
II
Panel
Cardiovascular
Clearances
46
Most recent
Sep 16, 2026
Median review, last 2 years
117 days
Third-party review
Not eligible
Implant
No

What it covers

To reduce vascular stenosis by dilatation and apposition of the cutting/scoring surfaces to the stenotic material

FDA’s definition of product code PNO, from the Product Classification database.

Recent clearances

510(k)DeviceApplicantDecisionType
K261778JADE SCORE PTA Scoring Balloon Dilatation CatheterOrbusNeich Medical (Shenzhen) Co., Ltd.Sep 16, 2026Traditional
K260012UltraScore™ Focused Force PTA BalloonBard Peripheral Vascular, Inc.Feb 4, 2026Special
K243944Aperta NSE PTA Balloon Dilatation CatheterGoodman Co., Ltd.Apr 22, 2025Traditional
K242254D·Kutting™ LL Peripheral Scoring Balloon Dilatation CatheterDk Medical Technology Co., Ltd.Apr 21, 2025Traditional
K241478Tri-Wedge PTA Scoring Balloon Dilatation CatheterBrosmed Medical Co., Ltd.Oct 22, 2024Traditional
K232258XO Constrain™ Percutaneous Transluminal Angioplasty Constraining CatheterTransit Scientific, LLCJun 17, 2024Traditional
K232013Aperta NSE PTA Balloon Dilatation Catheter (AW18-05040040/AA18-05040040, AW18-09040040/AA18-09040040, AW18-14540040, AW18-05050040/AA18-05050040, AW18-09050040/AA18-09050040, AW18-14550040, AW18-05060040/AA18-05060040, AW18-09060040/AA18-09060040, AW18-14560040 AW18-05070040/AA18-05070040, AW18-09070040/AA18-09070040, AW18-14570040, AW18-05080040/AA18-05080040, AW18-09080040/AA18-09080040, AW18-14580040)Goodman Co., Ltd.Mar 28, 2024Traditional
K232207D·Kutting™ PTA Scoring Balloon Dilatation CatheterDk Medical Technology Co., Ltd.Mar 7, 2024Traditional
K221986XO Score LP Percutaneous Transluminal Angioplasty Scoring Catheter, XO Score LP CatheterTransit Scientific, LLCOct 18, 2022Special
K220704Serranator PTA Serration Balloon CatheterCagent Vascular, LLCMay 4, 2022Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 46 with a free account)

Clearances by year

29 PNO 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)270
20252194
20244246
2022280
2021119
2020494
20191257
2017374
20161243
2015484
20141113
20131133
20121216
2011229

Who submits

17 applicants cleared a PNO device since 2011. 76% of the clearances went to applicants in United States, then China (14%), Japan (7%) and Ireland (3%). By type: Traditional 66% and Special 34%.

ApplicantClearances since 2011
Angioscore, Inc.5
Cagent Vascular, LLC5
Bard Peripheral Vascular, Inc.2
Dk Medical Technology Co., Ltd.2
Goodman Co., Ltd.2
Transit Scientific, LLC2
Boston Scientific Limited1
Brosmed Medical Co., Ltd.1

How FDA classifies it

Class II (performance standards).

From 21 CFR 870.1250.

Standards

21 CFR 870.1250 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent PNO clearances declared.

Ask about PNO

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about PNO

What is FDA product code PNO?

Product code PNO, “Catheter, Percutaneous, Cutting/Scoring” in FDA's classification database, is a Class II device type under 21 CFR 870.1250 (percutaneous catheter), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 46 clearances under PNO, 29 of them since 2011.

How many 510(k) clearances are there under PNO?

FDA’s 510(k) database listed 46 clearances under PNO as of Oct 29, 2026, 29 of them decided since 2011; the most recent decision was Sep 16, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a PNO 510(k)?

For the 4 PNO clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 117 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most PNO clearances?

Since 2011: Angioscore, Inc. (5), Cagent Vascular, LLC (5), Bard Peripheral Vascular, Inc. (2), Dk Medical Technology Co., Ltd. (2) and Goodman Co., Ltd. (2). 17 applicants have cleared a PNO device in that time.

Sources

  1. FDA product classification: PNO · Product Classification database
  2. 21 CFR 870.1250: Percutaneous catheter · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for PNO · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow PNOGet an email when FDA clears, recalls or publishes guidance for PNO devices.

Know what FDA already cleared.